Effect of lamotrigine on a novel model of epilepsy

Cytobios

Volumn 413, Issue 1 SUPPL., 2001, Pages 75-83

  Otoom, S A ^a   Nusier, M K ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Brain slice; CA1; Hippocampus; Lamotrigine; Spontaneous bursting; Therapeutic; Veratridine

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; TRIAZINE DERIVATIVE; VERATRIDINE;

ACTION POTENTIAL; ANIMAL; ARTICLE; BRAIN; CELL MEMBRANE POTENTIAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; MALE; MICROELECTRODE; MICROTOMY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; MALE; MEMBRANE POTENTIALS; MICROELECTRODES; MICROTOMY; RATS; RATS, SPRAGUE-DAWLEY; TRIAZINES; VERATRIDINE;

EID: 0347608927     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ALKADHI K. A. and Tian L. M. 1996. Veratridine-enhanced persistent sodium current induces bursting in CA1 pyramidal neurons. Neuroscience 71 625-32.
2. BRODIE M. J. 1998. Routine measurement of new antiepileptic drug concentrations: a critique and prediction. Adv. Neurol. 76 223-30.
3. CATTERALL W. A. 1980. Neurotoxins that act on voltage-sensitive sodium channels. A. Rev. Pharmacol. Toxicol. 20 15-43.
4. CHEUNG H., Kamp D. and Harris E. 1992. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 13 107-12.
5. DICHTER M. A. 1994. The epilepsies and convulsive disorders. In Huffison's Principles of Internal Medicine. Thirteenth editn. Edited by K. J. Isselbacher et al. McGraw-Hill Inc., U.S.A.
6. DICHTER M. A. and Brodie M. J. 1996. New antiepileptic drugs. New Engl. J. Med. 334 1583-90.
7. HILLE B. 1992. Modifiers of gating. In Ionic Channels of Excitable Membranes. p 445. Edited by M. A. Sunderland (Sinauer).
8. LANG D. G., Wang C. M. and Cooper B. R. 1993. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TGI mouse neuroblastoma cells. J. Pharmacol. exp. Ther. 266 829-35.
9. LEACH M. J., Marden C. M. and Miller A. A. 1986. Pharmacological studies on lamotrigine: a novel potential antiepileptic drug. 2. Neurochemical studies on the mechanism of action. Epllepsia 27 490-7.
10. MELDRUM B. S. 1986. Preclinical test systems for evaluation of novel compounds. In New Anticonvulsant Drugs. pp 17-30. Edited by B. S. Meldrum and R. J. Porter.
11. MILLER A. A., Wheatley P., Sawyer D. A., Baxter M. G. and Roth B. 1986. Pharmacological studies on lamotrigine: a novel potential antiepileptic drug. 1. Anticonvulsant profile in mice and rats. Epilepsia 27 483-9.
12. OTOOM S., Tian L. M. and Alkadhi K. A. 1998. Veratridine-treated brain slices: a cellular model for epileptiform activity. Brain Res. 789 150-6.
13. PEDLEY T. A. 1992. Classification of seizures and epilepsy. In The Medical Treatment of Epilepsy, pp 3-15. Edited by S. R. Resor Jr and H. Kutt. Marcel Dekker Inc., New York, U.S.A.
14. RICHENS A. and Yuen A. W. C. 1991. Overview of the clinical efficacy of lamotrigine. Epilepsia 32 S13-S16.
15. WANG S. J., Huang C. C., Hsu K. S., Tsai J. J. and Gean P. W. 1996. Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons. Synapse 24 248-55.
16. + channels in rat hippocampal neurons. Eur. J. Physiol. 430 437-46.